{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T09:28:52Z","timestamp":1676885332967},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.pupt.2011.04.002","type":"journal-article","created":{"date-parts":[[2011,4,15]],"date-time":"2011-04-15T17:42:39Z","timestamp":1302889359000},"page":"426-433","source":"Crossref","is-referenced-by-count":4,"title":["An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis"],"prefix":"10.1016","volume":"24","author":[{"given":"Paul","family":"Ratner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Wingertzahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh Y.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruediger","family":"Nave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.pupt.2011.04.002_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2011.04.002_bib2","first-page":"1440","article-title":"Treatment of allergic rhinitis","volume":"12","author":"Sur","year":"2010","journal-title":"Am Fam Physician"},{"issue":"Suppl. 2","key":"10.1016\/j.pupt.2011.04.002_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","author":"Wallace","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2011.04.002_bib4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1398-9995.2008.01750.x","article-title":"Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications","volume":"10","author":"Derendorf","year":"2008","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.pupt.2011.04.002_bib5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bcp.2007.01.031","article-title":"The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue","volume":"73","author":"Mutch","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pupt.2011.04.002_bib6","unstructured":"Alvesco\u00ae prescribing information; 2008 [last accessed 30.05.10]."},{"key":"10.1016\/j.pupt.2011.04.002_bib7","unstructured":"Omnaris\u00ae prescribing information. 2010 [last accessed 30.05.10]."},{"issue":"4","key":"10.1016\/j.pupt.2011.04.002_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270006286437","article-title":"Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis","volume":"46","author":"Nave","year":"2006","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.pupt.2011.04.002_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2006.07.050","article-title":"Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis","volume":"118","author":"Ratner","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pupt.2011.04.002_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1081-1206(10)60693-X","article-title":"Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis","volume":"98","author":"Meltzer","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.pupt.2011.04.002_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1081-1206(10)60624-2","article-title":"Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis","volume":"99","author":"Chervinsky","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2011.04.002_bib12","series-title":"Guidance for industry, allergic rhinitis: clinical development","author":"Food and Drug Administration","year":"2000"},{"key":"10.1016\/j.pupt.2011.04.002_bib13","series-title":"Declaration of Helsinki. Ethical principles for medical research involving human subjects","year":"2008"},{"key":"10.1016\/j.pupt.2011.04.002_bib14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1081-1206(10)60171-8","article-title":"Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis","volume":"2","author":"Laforce","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2011.04.002_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.anai.2010.09.024","article-title":"Evaluation of the efficacy and safety of ciclesonide HFA nasal aerosol 80 \u03bcg or 160 \u03bcg once daily for the treatment of seasonal allergic rhinitis","volume":"105","author":"Ratner","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2011.04.002_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yapd.2006.04.006","article-title":"Effects of inhaled steroids on growth, bone metabolism, and adrenal function","volume":"53","author":"Allen","year":"2006","journal-title":"Adv Pediatr"},{"issue":"2","key":"10.1016\/j.pupt.2011.04.002_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2500\/aap.2007.28.2948","article-title":"Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis","volume":"28","author":"Blaiss","year":"2007","journal-title":"Allergy Asthma Proc"},{"issue":"7","key":"10.1016\/j.pupt.2011.04.002_bib18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/02770900701496007","article-title":"Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients","volume":"44","author":"Kim","year":"2007","journal-title":"J\u00a0Asthma"},{"issue":"8","key":"10.1016\/j.pupt.2011.04.002_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/02770900701554359","article-title":"Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis","volume":"44","author":"Ratner","year":"2007","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.pupt.2011.04.002_bib20","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.clinthera.2009.12.002","volume":"12","author":"Nave","year":"2009","journal-title":"Clin Ther"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553911000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553911000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T08:22:23Z","timestamp":1543825343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553911000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1094553911000460"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2011.04.002","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}